Prostate cancer is common in men, but advanced cases can be tough to treat. Our doctors use radioligand therapy with Lutetium-177 to target and kill prostate cancer cells. While not a cure, it improves quality of life and offers more time. This success shapes the future of advanced prostate cancer treatment. Subscribe for more health insights from Mayo Clinic.
#prostatecancertreatment #RadioligandTherapy #CancerTreatment #MayoClinic #HealthTips
Learn more: [ Ссылка ]
From Mayo Clinic to your inbox, sign-up for free: [ Ссылка ]
Visit Mayo Clinic: [ Ссылка ]
Like Mayo Clinic on Facebook: [ Ссылка ]
Follow Mayo Clinic on Instagram: [ Ссылка ]
Follow Mayo Clinic on X, formerly Twitter: [ Ссылка ]
Follow Mayo Clinic on Threads: [ Ссылка ]
